BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anan A, Baskin-Bey ES, Isomoto H, Mott JL, Bronk SF, Albrecht JH, Gores GJ. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse. Am J Physiol Gastrointest Liver Physiol. 2006;291:G709-G716. [PMID: 16798723 DOI: 10.1152/ajpgi.00126.2006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Chakraborty JB, Mann DA. NF-kappaB signalling: embracing complexity to achieve translation. J Hepatol. 2010;52:285-291. [PMID: 20022129 DOI: 10.1016/j.jhep.2009.10.030] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
2 Bertinat R, Pontigo JP, Pérez M, Concha II, San Martín R, Guinovart JJ, Slebe JC, Yáñez AJ. Nuclear accumulation of fructose 1,6-bisphosphatase is impaired in diabetic rat liver. J Cell Biochem 2012;113:848-56. [PMID: 22021109 DOI: 10.1002/jcb.23413] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fineschi S, Bongiovanni M, Donati Y, Djaafar S, Naso F, Goffin L, Argiroffo CB, Pache JC, Dayer JM, Ferrari-Lacraz S, Chizzolini C. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis. Am J Respir Cell Mol Biol 2008;39:458-65. [PMID: 18458239 DOI: 10.1165/rcmb.2007-0320OC] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
4 Hsieh WT, Tsai CT, Wu JB, Hsiao HB, Yang LC, Lin WC. Kinsenoside, a high yielding constituent from Anoectochilus formosanus, inhibits carbon tetrachloride induced Kupffer cells mediated liver damage. J Ethnopharmacol 2011;135:440-9. [PMID: 21470577 DOI: 10.1016/j.jep.2011.03.040] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
5 Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 2007;39:695-714. [PMID: 17110155 DOI: 10.1016/j.biocel.2006.10.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
6 Sosa Seda IM, Mott JL, Akazawa Y, Barreyro FJ, Bronk SF, Kaufmann SH, Gores GJ. Noxa mediates hepatic stellate cell apoptosis by proteasome inhibition. Hepatol Res 2010;40:701-10. [PMID: 20557369 DOI: 10.1111/j.1872-034X.2010.00668.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Xia SW, Wang ZM, Sun SM, Su Y, Li ZH, Shao JJ, Tan SZ, Chen AP, Wang SJ, Zhang ZL, Zhang F, Zheng SZ. Endoplasmic reticulum stress and protein degradation in chronic liver disease. Pharmacol Res 2020;161:105218. [PMID: 33007418 DOI: 10.1016/j.phrs.2020.105218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Rickmann M, Vaquero EC, Malagelada JR, Molero X. Tocotrienols induce apoptosis and autophagy in rat pancreatic stellate cells through the mitochondrial death pathway. Gastroenterology. 2007;132:2518-2532. [PMID: 17570223 DOI: 10.1053/j.gastro.2007.03.107] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
9 Ramachandran S, Liaw JM, Jia J, Glasgow SC, Liu W, Csontos K, Upadhya GA, Mohanakumar T, Chapman WC. Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation. Transpl Immunol. 2012;26:201-206. [PMID: 22286145 DOI: 10.1016/j.trim.2012.01.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
10 Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Gastroenterology. 2009;137:297-308, 308.e1-4. [PMID: 19208365 DOI: 10.1053/j.gastro.2009.01.068] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
11 Mao X, Pan X, Zhao S, Peng X, Cheng T, Zhang X. Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. Inflammation 2012;35:1378-91. [PMID: 22391745 DOI: 10.1007/s10753-012-9451-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Padrissa-Altés S, Zaouali MA, Bartrons R, Roselló-Catafau J. Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms. Clin Sci (Lond). 2012;123:93-98. [PMID: 22455352 DOI: 10.1042/cs20110093] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
13 Goffin L, Seguin-Estévez Q, Alvarez M, Reith W, Chizzolini C. Transcriptional regulation of matrix metalloproteinase-1 and collagen 1A2 explains the anti-fibrotic effect exerted by proteasome inhibition in human dermal fibroblasts. Arthritis Res Ther 2010;12:R73. [PMID: 20429888 DOI: 10.1186/ar2991] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
14 Kim GP, Mahoney MR, Szydlo D, Mok TS, Marshke R, Holen K, Picus J, Boyer M, Pitot HC, Rubin J. An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma. Invest New Drugs. 2012;30:387-394. [PMID: 20839030 DOI: 10.1007/s10637-010-9532-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
15 Padrissa-Altés S, Zaouali MA, Boncompagni E, Bonaccorsi-Riani E, Carbonell T, Bardag-Gorce F, Oliva J, French SW, Bartrons R, Roselló-Catafau J. The use of a reversible proteasome inhibitor in a model of Reduced-Size Orthotopic Liver transplantation in rats. Exp Mol Pathol. 2012;93:99-110. [PMID: 22475623 DOI: 10.1016/j.yexmp.2012.03.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
16 Santamaría E, Mora MI, Muñoz J, Sánchez-quiles V, Fernández-irigoyen J, Prieto J, Corrales FJ. Regulation of stathmin phosphorylation in mouse liver progenitor-29 cells during proteasome inhibition. Proteomics 2009;9:4495-506. [DOI: 10.1002/pmic.200900110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
17 Llerena S, Arias-Loste MT, Puente A, Cabezas J, Crespo J, Fábrega E. Binge drinking: Burden of liver disease and beyond. World J Hepatol 2015; 7(27): 2703-2715 [PMID: 26644814 DOI: 10.4254/wjh.v7.i27.2703] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
18 Lee S, Kim JH, Lee JH, Choi SY. Image Monitoring of the Impaired Phagocytic Activity of Kupffer Cells and Liver Oxygen Saturation in a Mouse Cholangitis Model Using Contrast-Enhanced Ultrasound Imaging and Photoacoustic Imaging. Ultrasound Med Biol 2017;43:2461-8. [PMID: 28673477 DOI: 10.1016/j.ultrasmedbio.2017.05.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Tilahun AY, Theuer JE, Patel R, David CS, Rajagopalan G. Detrimental effect of the proteasome inhibitor, bortezomib in bacterial superantigen- and lipopolysaccharide-induced systemic inflammation. Mol Ther 2010;18:1143-54. [PMID: 20372109 DOI: 10.1038/mt.2010.53] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]